Category: Pharmaceutical

Categories
Pharmaceutical

Rising Demand Of High Frequency Ventilators Market By Growing Chronic Respiratory Diseases In The Preterm Births

The High Frequency Ventilators market is undergoing critical developments in its landscape. It is setting the tone for future competition as well as paving the road to growth over the forecast period. As per the World Health Organization (WHO) worldwide incidences of preterm births stand at around 15 million each year and around 1 million babies die before the age of 5. Across all 184 countries, where WHO carried out surveys, preterm births ranged from 5% to 18% of total births.

The growth of the High Frequency Ventilators market is attributed to some key driving factors such as increasing awareness regarding respiratory diseases and growing healthcare expenditure by government. However, resistance from physicians regarding technology transformation may hamper the growth of this High Frequency Ventilators.

Growing awareness about management of preterm births is expected to further fuel the global high frequency ventilators market.

Get an Idea about the Offerings of Our High Frequency Ventilators Market Report from this Brochure: https://www.factmr.com/connectus/sample?flag=B&rep_id=1693

High Frequency Ventilators Market size is done based on a triangulation methodology that is primarily based on experimental modelling approaches such as patient-level data or disease epidemiology for any key indications , number of procedures and install base analysis for any equipment to obtain precise market estimations  for the base year as well as in historic data analysis. Bottom-up approach is always used to obtain High Frequency Ventilators insightful data for the specific country/regions. The country specific data is again analyzed to derive data at a global level. Specific factors/parameters are considered related to the individual Keyword market and quantified with insightful rationale

The report covers exhaust analysis on:

  • Market Segments
  • Market Dynamics
  • Market Size
  • Supply & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Indication
  • Value Chain

High Frequency Ventilators Market: Key Players

Some of the global key participants operating in high frequency ventilators market are

  • Inspiration Healthcare Group plc,
  • BVMed eV Berlin,
  • Metan Co. Ltd.,
  • VYAIRE,
  • nternational Biomedical,
  • ACUTRONIC Medical Systems AG,
  • Percussionaire Corp,
  • Carl Reiner GmbH and others.

Expanding Operations in Future? To Get the Perfect Launch Ask for a Custom High frequency ventilators Market Report  https://www.factmr.com/connectus/sample?flag=RC&rep_id=1693

 

High Frequency Ventilators Market: Segmentation

The global high frequency ventilators market can be segmented on the basis of product type, end user and geography.

Based on product type, the high frequency ventilators market is segmented as:

  • Oscillating high frequency ventilators
  • Jet high frequency ventilators
  • High-frequency flow interrupters

Based on end user, the high frequency ventilators market is segmented as:

  • Hospitals
  • Ambulatory surgical centers
  • Others

Ask for TOC here- https://www.factmr.com/connectus/sample?flag=T&rep_id=1693

Reasons to Buy this High Frequency Ventilators Market Report:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the High Frequency Ventilators market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global High Frequency Ventilators market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global High Frequency Ventilators market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Read More Trending Reports of Fact.MR- https://www.prnewswire.com/news-releases/medical-videoscopes-market-sees-new-dawn-with-top-brands-launching-disposable-bronchoscopes-to-capture-us-3-bn-opportunity-301351038.html

Explore Fact.MR’s Comprehensive Coverage on Healthcare Landscape

Interventional ENT Devices Market– The market is driven by the increasing number of reported ENT disorders. Technology has led the market to adopt new methods in order to form interventional ENT devices, which are minimally invasive in its approach as the rush for minimally invasive methods in healthcare sector is rising.

Mild Laxatives Market– The growing prevalence and recurrence of constipation is expected to be the major factor driving the growth of the mild laxatives market over the forecast period.

Artificial Eye Lenses Market– The artificial eye lens market is expected to witness exponential growth over the forecast period due to rise in number of patients going for cataract surgeries and more number of patients suffering from cataract.

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:

11140 Rockville Pike

Suite 400

Rockville, MD 20852

United States

Tel: +1 (628) 251-1583

 

Corporate Headquarter:

Unit No: AU-01-H Gold Tower (AU),

Plot No: JLT-PH1-I3A,

Jumeirah Lakes Towers,

Dubai, United Arab Emirates

Email: sales@factmr.com

 

Categories
Pharmaceutical

Rising Demand for ENT Workstations Is Expected To Boost Market in Medical Sector during the Next Few Years, Says Fact.MR

The growing demand for ENT workstations indicated for ENT procedure, which are capable of offering a protective environment to the patient and easy accessibility of tools to the doctor, is expected to be a major factor driving the ENT workstation market over the forecast period. Moreover, changing trends and growing developments in biotech industry is likely to fuel the growth of ENT workstations market in the near future. Rising demand for ENT workstations in the medical sector is also another driving factor that is expected to boom the market size during the next few years.

ENT workstations Market size is done based on a triangulation methodology that is primarily based on experimental modelling approaches such as patient-level data or disease epidemiology for any key indications , number of procedures and install base analysis for any equipment to obtain precise market estimations  for the base year as well as in historic data analysis.

Are you a start-up willing to make it big in business? Grab an exclusive PDF Brochure for this report https://www.factmr.com/connectus/sample?flag=S&rep_id=1769

ENT Workstation is the focus of the new ENT treatment system and provides all the functions you need to treat your patients with an alternative. Trends in the global ENT workstations market include market consolidation and technological advancements in products. However, ENT workstations require very expensive apparatus, which can result in a high initial set up cost. These factors are likely to restrict the use of ENT workstations.

Based on Product, the market is bifurcated into Fixed ENT Workstation and Portable ENT Workstation. Fixed ENT workstations are those which consists of multiple monitoring and procedural equipment. These are multifunctional and ease the work of the operator. Portable ENT workstations are stationary in one place and the operator or the healthcare professional has to operate it, this type of workstation limit of activity of the healthcare professional.

Based on End User, the market is bifurcated into Hospital, Clinic, and Others. Hospital is a health care institution with medical and nursing specialists and medical supplies for patients. The most common form of hospital is the general hospital, which normally has an emergency room for treating urgent health issues ranging from victims of fires and injuries to sudden diseases.

Based on regional analysis, the Global ENT Workstations Market is classified into North America, Europe, Asia Pacific, and Rest of the world. North America is one of the significant consumers of the ENT workstations market. This growth is mainly attributed to the early adoption and development of ENT workstations and increasing personal disposable income. The ENT workstations market in Asia Pacific is estimated to expand at a rapid pace in the region during the forecast period.

To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our Sales Team at https://www.factmr.com/connectus/sample?flag=RM&rep_id=1769

The major players in the market are

  • ANA-MED,
  • ATMOS MedizinTechnik,
  • Chammed,
  • Dantschke,
  • Entermed,
  • Euroclinic Medi-Care Solutions,
  • Foshan Gladent Medical,
  • GAES Medical,
  • Global Surgical Corporation and
  • Heinemann Medizintechnik

The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Ask for TOC here- https://www.factmr.com/connectus/sample?flag=T&rep_id=1769

Reasons to Purchase this Report:

  • Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
  • Provision of market value (USD Billion) data for each segment and sub-segment
  • Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
  • Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
  • Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
  • Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
  • The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
  • Includes an in-depth analysis of the market of various perspectives through Porter’s five forces analysis
  • Provides insight into the market through Value Chain
  • Market dynamics scenario, along with growth opportunities of the market in the years to come

Frequently Asked Questions

What are the key driving factors for the ENT Workstations Market?

The Global EENT Workstations Market is primarily driven by the growing demand for usage of qualitative modern equipment to perform ENT procedures across the globe. Moreover, changing trends and growing developments in biotech industry is likely to fuel the growth of ENT workstations market in the near future.

What are the top players operative in ENT Workstations Market?

The major players in the market are ANA-MED, ATMOS MedizinTechnik, Chammed, Dantschke, Entermed, Euroclinic Medi-Care Solutions, Foshan Gladent Medical, GAES Medical, Global Surgical Corporation and Heinemann Medizintechnik.

What segments are covered in ENT Workstations Market?

The Global ENT Workstations Market is segmented On The Basis of Product, End User, And Geography.

How can get sample reports/company profiles of ENT Workstations Market?

The report sample for ENT Workstations Market report can be obtained on demand from the website. Also, the 24*7 chat support & direct call services are provided to procure the sample report.

Read More Trending Reports of Fact.MR-

http://www.globenewswire.com/en/news-release/2019/07/29/1892912/0/en/Dental-Anesthetics-Sales-Will-Witness-a-Promising-Leap-as-Dental-Tourism-Continues-to-Proliferate-Says-Fact-MR.html

Explore Fact.MR’s Comprehensive Coverage on Healthcare Landscape

Hyperemesis Gravidarum Treatment Market- The global market for hyperemesis gravidarum treatment is expected to witness significant growth over the forecast period as the demand for prescription drugs over the OTCs for hyperemesis gravidarum treatment is high in developing countries, as they have less side effects and better efficacy.

ENT Cameras Market–  The ENT cameras are increasingly getting adopted accustomed to the cosmetic advancements.

Tear Duct Plugs Market- Tear duct plugs provide a simple treatment option for chronic dry eye conditions. Dry eye is a very common condition wherein lack of sufficient moisture and lubrication on the surface of the eye leads to dry eye syndrome.

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:

11140 Rockville Pike

Suite 400

Rockville, MD 20852

United States

Tel: +1 (628) 251-1583

Corporate Headquarter:

Unit No: AU-01-H Gold Tower (AU),

Plot No: JLT-PH1-I3A,

Jumeirah Lakes Towers,

Dubai, United Arab Emirates

Email: sales@factmr.com

Categories
Pharmaceutical

Venous Procedure Devices Market is projected to surpass US$ 3 billion valuation by 2031, Reveals Fact.MR

Award-winning consulting firm Fact.MR recently published a report on the global demand of venous procedure devices market, for the forecast period 2021-2031. According to the study, the market is projected to surpass US$ 3 billion in value by the end of the aforementioned forecast period (2021 to 2031), expanding at a CAGR of around 6%. Growth is majorly influenced by an increase in vascular disease procedures.

Historically, the market posted credible gains, being valued at around US$ 2 billion in 2019. A host of established as well as incumbent market players are scrambling to secure a firm footing in the landscape. AIincreasing number of startups are capitalizing on incremental opportunities presented by key segments across the venous procedure devices market.

Request a report sample to gain comprehensive insights at https://www.factmr.com/connectus/sample?flag=S&rep_id=5966

Inari Medical, for instance, offers the Flow Triever catheter-based thrombectomy device shown to extract significant amounts of clot from large blood vessels. It has a self-expanding Nitinol framework designed to engage, disrupt and remove emboli from blood vessels with minimal trauma. Likewise, Silk Road Medical produces devices for Transcarotid artery revascularization (TAR) procedure for carotid artery disease. Its products include the EnRoute Transcarotid Neuroprotection and the EnRoute Stent system.

venous procedure devices market

Key Takeaways from Market Study
  • By product, central venous catheters to experience sharp incline amid greater effectiveness
  • By application, chest venous procedure devices to remain dominant, abdomen devices uptake expanding rapidly
  • Venous procedure devices for vascular diseases will experience robust incline through 2031
  • By end user, hospitals to remain primary source of venous procedure devices implanting
  • The U.S. to emerge as a potential growth hotspot amid increased prevalence of peripheral arterial disease
  • India to cement its dominance across the South Asian market
“Purpose-built venous stents offer promising growth prospects, attributed to their ability to achieve efficient arterial pulsation and mobility for treating occlusion diseases. Hence, prominent manufacturers are collaborating with medical technology consulting firms to deepen their outreach,”

comments a Fact.MR analyst.

Request More Information about Report Methodology
https://www.factmr.com/connectus/sample?flag=RM&rep_id=5966

Competitive Landscape

Medtronic Plc., Abbott Laboratories, Cook Medical, Cardinal Health, Becton Dickinson & Co. (BD), Terumo Corporation, Boston Scientific Corporation and Teleflex are some prominent venous procedure devices manufacturers. Most players rely on introducing new devices post regulatory approvals across key geographies, in addition to other expansion strategies such as collaborations, mergers & acquisitions and partnerships respectively.

  • For instance, in May 2019, Cordis, a Cardinal Health company, announced the full US launch of its RADIAL 360 portfolio, offering a complete range of products to facilitate the tranradial approach (TRA) for interventional cardiology. The portfolio consists of RAIN SheathTM Transradial Thin-Walled Introducer, RAILWAYTM Sheathless Access System and the ZEPHYR® Vascular Compression Brand among others
  • In April 2021, Becton Dickinson (BD) announced enrollment in its post-market studies of the WavelinQTM Arteriovenous Endovascular Fistula device which uses concomitant ulnar artery and ulnar vein in patients suffering from chronic kidney diseases, expected to enroll 280 participants through 30 days

Get More Insights- https://www.biospace.com/article/global-venous-procedure-devices-market-to-exceed-valuation-of-us-3-billion-by-2031-fact-mr/

More Valuable Insights Available

Fact.MR, in its new offering, presents an unbiased analysis of the venous procedure devices market, presenting historical demand data (2016-2020) and forecast statistics for the period of 2021-2031. The study divulges essential insights on the market on the basis of product (stents, catheters, and others), application (leg, chest, abdomen, and arm), indication (vascular diseases and cancer), and end user (hospitals, ambulatory surgical centers, specialty clinics, and others) across five major regions of the world (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa).

Explore Fact.MR’s Coverage on the Healthcare Domain

Intravenous Solutions Market: Intravenous solutions market is set to witness considerable growth during 2021-2031. The outbreak of pandemic and emergence of new strains is augmenting the demand for intravenous solutions.

Cardiovascular OCT Imaging Market: The global cardiovascular OCT imaging market is estimated to demonstrate a steady growth rate as the market for OCT imagining is growing rapidly, which is subsequently boosting the adoption of cardiovascular OCT imaging.

Intravascular Catheters Market: The intravascular catheters market is set to witness steady growth during 2021-2031. Demand for intravascular catheters expects to witness steady recovery in the short term, with an optimistic growth outlook in the long run.

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com
Research Insight: https://www.factmr.com/report/venous-procedure-devices-market
Press Release: https://www.factmr.com/media-release/1981/global-venous-procedure-devices-market

Categories
Pharmaceutical

Hyperthermia Cancer Treatment Market to See Huge Growth by 2031 | Companies Gamida-Cell Ltd., OncothermKft, Hydrosun GmbH

Award-winning consulting firm Fact.MR has recently published an extensive report on the global market demand for hyperthermia cancer treatment for the forecast period of 2021-2031. According to the study, the market is anticipated to accrue impressive gains, expanding at a CAGR of around 6% to surpass a valuation of US$ 250 million by 2031. Rising cancer prevalence is attributed as the chief growth driver for this market.

The International Agency for Research on Cancer (IARC) estimates that, globally, 1 in 5 people develop cancer during their lifetime, and 1 in 8 men and 1 in 11 women die from the disease, respectively. These new estimates suggest that more than 50 million people are living within five years of a past cancer diagnosis. Also, according to the World Health Organization, breast cancer is the most commonly occurring cancer in women and the second-most common cancer overall. Over 2 million new cases of breast cancer were diagnosed across the world in 2018. Hence, the scope for incorporating sophisticated treatments is increasing, paving way for enhanced adoption of hyperthermia cancer treatment.

Request a report sample to gain comprehensive insights at
https://www.factmr.com/connectus/sample?flag=S&rep_id=5877

Furthermore, various governmental initiatives to fund extensive cancer research programs are proving to be a boon for market growth. For instance, in April 2016, the U.S. Government allotted US$ 5.2 billion to the National Cancer Institute (NCI) for cancer research and training. This has enabled the U.S. healthcare system to deploy a host of advanced cancer treatment and diagnosis solutions.

Key Take aways from Market Study
  • Microwave hyperthermia cancer treatment devices to account for over 40% revenue share through 2031
  • By application, treatment for breast cancer to remain key revenue generator
  • Prospects for deep tissue ®ional perfusion appear highly promising, expected to post significant gains
  • By enduser, hospitals to yield over two-fifth of the global revenue share through 2031
  • High cancer incidence and prevalence rates to stimulate demand across the U.S.
  • The U.K. to stimulate high demand amid growing preference for minimally invasive cancer treatment
  • Rapid advancements in medical technology to bolster uptake across France and Germany

hyperthermia cancer treatment market

“Rising demand for improving clinical outcomes and inflicting minimal patient discomfort is prompting healthcare providers to deploy a broad range of advanced surgical and therapeutic options, including high intensity focused ultrasound (HIFU), widening the growth prospects of market players,” says a Fact.MR analyst.

Request More Information about Report Methodology
https://www.factmr.com/connectus/sample?flag=RM&rep_id=5877

Key Drivers

  • Rising prevalence of cancers such as breast and prostate cancers will fuel the demand for hyperthermia cancer treatment.
  • Increasing demand for non-invasive diagnostic treatment will spur the growth of the market.
  • Growing awareness about the diagnostics and treatment for cancers will thrust the demand for hyperthermia cancer treatment.

Key Restraints

  • Lack of adequate skills and experience to conduct hyperthermia cancer treatment surgeries is negatively affecting growth.
  • High costs of hyperthermia cancer treatment are a factor hampering the market growth.

Get More Insights- https://www.biospace.com/article/rise-in-the-demand-for-non-invasive-cancer-treatment-driving-the-hyperthermia-cancer-treatment-market-fact-mr/

Competitive Landscape

Prominent players operating in the hyperthermia cancer treatment market profiled by Fact.MR includes PYREXAR Medical, Celsius42 GmbH, Hydrosun GmbH, Oncotherm Kft., Andromedic S.r.l., Yamamoto Vinita Co. Ltd, Chongqing Haifu Medical, Technology Co. Ltd., innoMedicus Ltd., Gamida-Cell Ltd., and RanD. Key market players are focusing on new approaches to treat and diagnose potential cancers and strengthen their distribution networks to maintain their leading in the market.

  • innoMedicus Ltd. published a study in JAMA Oncology, establishing that non-contrast MRI yields better diagnosis of prostate cancer in 2021.
  • Gamida Cell announced a collaboration with Highbridge Capital Management to further its Omidubicel and GDA-201 clinical development.

Explore Fact. MR’s Coverage on the Healthcare Domain

Cancer Therapeutics Market – With the recent discoveries of innovative peptide-based medications that can improve the efficacy of conventional treatments, the global market for cancer therapeutics has been growing. The search for natural and synthetic proteasome inhibitors is stimulating research and development efforts in the landscape, which is projected to revolutionize the cancer therapeutics market for peptide-based therapies.

Cancer Profiling Market – The identification of the target mutation by cancer profiling aids in the development of a highly targeted medicine that provides long-term remission and a longer life expectancy. The genetic information of an individual, as well as his or her cancer cell profile, are used in the personalized medicine approach to cancer treatment. Ongoing R&D operations in the field of precision oncology present profitable opportunities for cancer profiling manufacturers.

Market for Cancer Biomarkers – The Prostate-Specific Antigen (PSA) test sector, which accounts for approximately one-fifth of the global cancer biomarkers market, is closely followed by the CTC test segment. North America continues to be the most important market, accounting for major share of the global market for cancer biomarkers. During the projected period, this is expected to gain even more traction.

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com
Research Insight: https://www.factmr.com/report/hyperthermia-cancer-treatment-market
Press Release: https://www.factmr.com/media-release/1969/global-hyperthermia-cancer-treatment-market

Categories
Pharmaceutical

Aseptic Transfer System Market is set to surpass a US$ 1.5 billion valuation by 2031, Finds Fact.MR

Sales of aseptic transfer systems are gaining traction with increasing demand from pharmaceutical companies, research laboratories, and other key end-use sectors. As the requirement for liquid transfer systems and solid transfer systems is becoming prominent across the world, aseptic transfer system manufacturers are expected to experience higher growth over the coming years, with the pharmaceutical sector being the main end user.

According to a new report by Fact.MR, North America, Europe, and Asia Pacific will remain major markets for aseptic transfer systems, while the overall industry value will surpass a valuation of US$ 1.5 billion by 2031, expanding at a healthy CAGR of 6.5% over the next ten years.

Request a report sample to gain comprehensive insights at
https://www.factmr.com/connectus/sample?flag=S&rep_id=6088

Key Takeaways from Market Study
  • High demand for liquid transfer systems likely to be witnessed.
  • Increase in demand from pharmaceutical sector to boost overall sales.
  • The United States to lead demand for aseptic transfer systems in North America.
  • Germany to take center stage in Europe’s market for aseptic transfer systems.
  • Asia Pacific to emerge as the fastest-growing market for aseptic transfer systems.
  • China, Japan, the United Kingdom, India, France, and Canada to maintain positive industry outlook during the forecast period.
“As the pharmaceutical sector is becoming more advanced, demand for aseptic transfer systems is surging. Additionally, rising preference for single-use aseptic transfer systems is set to propel the growth of suppliers further over the coming years,”

says a Fact.MR analyst.

aseptic transfer system market

Pharmaceutical Sector to Lead Demand for Aseptic Transfer Systems

Aseptic transfer systems are highly sought-after in the pharmaceutical sector for the secure transfer of fluids, components, powders, and others. With increase in adoption of advanced technologies by the pharmaceutical sector, suppliers of aseptic transfer systems are subject to come across lucrative growth scope in the near future.

Get Customization on this Report for Specific Research Solutions
https://www.factmr.com/connectus/sample?flag=RC&rep_id=6088

According to a report published by SelectUSA, the United States pharmaceutical sector is one of the largest in the world, while U.S. firms conduct over half the world’s research & development (R&D) in pharmaceuticals, which is worth US$ 75 billion. As stated in a report published by the European Medicines Agency, Europe’s pharmaceutical industry is highly progressive and projected to grow significantly, owing to increasing investments by governments and various initiatives. These factors give a glimpse of the growing opportunities for aseptic transfer system suppliers around the world.

Aseptic transfer system market: Key Findings
  • The global aseptic transfer system market is gaining popularity and attention and is expected to surpass a valuation of US$ 1.5 billion by the end of forecast period.
  • US is expected to dominate the North American market on the backs of advance healthcare infrastructure and modernized pharmaceutical industry.
  • Europe is predicted to offer lucrative growth opportunities for aseptic transfer system market owing to booming pharmaceutical manufacturing industry.
  • China has become the epicenter for aseptic transfer system suppliers. Rising geriatric population and increased consumer spending on healthcare will further propel the market growth.
  • Thriving pharmaceutical sector and increased research and development activities in India will escalate market sales.

Get More Insights- https://www.biospace.com/article/burgeoning-need-for-cns-agents-and-gi-drugs-will-improve-animal-drug-compounding-demand-fact-mr/

More Valuable Insights

In its latest report, Fact.MR offers an unbiased analysis of the aseptic transfer system market, providing historical data for the period of 2016-2020 and forecast statistics for the period of 2021-2031. In order to understand the global market potential, its growth, and scope, the market is segmented on the basis of product (liquid transfer systems and solid transfer systems), usability (single use and multiple use), and end-use industry (pharmaceutical companies, research laboratories, and others), across seven major regions of the world (North America, Latin America, Europe, East Asia, South Asia, Oceania, and MEA).

Explore Fact.MR’s Coverage on the Healthcare Domain

Hand hygiene monitoring system market: The global hand hygiene monitoring system market study published by Fact.MR offers an unbiased analysis of the prominent drivers, opportunities and trends expected to shape future expansion outlook. The report provides a comprehensive assessment on the prominent segments and geographies which are likely to benefit market players in forthcoming years.

Blood thawing system market: Fact.MR’s extensive coverage on the blood thawing system market offers in-depth insights about the prominent growth dynamics that are likely to aid expansion of growth prospects in the near future. Data has been presented in the form of key segments across prominent geographies, along with important information concerning key manufacturers operating within the industry.

Hyperinflation system market: A recent study by Fact.MR on the hyperinflation system market offers a 10-year forecast analysis for the period 2018 to 2028. The study analyzes key trends that are currently determining the growth of the market. This report covers key dynamics, including drivers, restraints, and opportunities for leading market players along with key stakeholders and emerging players.

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com
Research Insight: https://www.factmr.com/report/aseptic-transfer-system-market
Press Release: https://www.factmr.com/media-release/1962/global-aseptic-transfer-system-market

Categories
Pharmaceutical

Animal Drug Compounding Market worth US$ 155 billion by 2031 – Exclusive Report by Fact.MR

As stated in a new report by Fact.MR, North America and Europe will emerge as leading regional markets for animal drug compounding, while Asia Pacific will exhibit the fastest growth throughout the forecast period of 2021 to 2031. The global animal drug compounding market is projected to progress at a moderate CAGR over the next ten years.

Surging demand due for various animal drug compounding products such as CNS agents, GI drugs due to the increasing requirements within the pharmaceutical sector is bolstering the market growth. Rise in requirement for oral route of administration for animal drug compounding and demand for anti-infectives will rise the fastest, accelerating the animal drug compounding demand.

Request a report sample to gain comprehensive insights at
https://www.factmr.com/connectus/sample?flag=S&rep_id=5796

Key Takeaways from Market Study
  • High requirement for anti-infectives likely to be witnessed.
  • Oral and injectable segments to boost sales in terms of route of administration.
  • Companion animal segment to emerge lucrative across regions.
  • Capsule and suspension forms of dosage to augment demand growth.
  • The United States remain a huge market for animal drug compounding.
  • Germany to exhibit hegemony in Europe’s market for animal drug compounding.
  • Asia Pacific to emerge the fastest-growing region for manufacturers of animal drug compounding products.
  • The United Kingdom, China, South Korea, France, and Canada to remain high-potential markets throughout the forecast period.
“The market is subject to steady growth owing to increase in requirement for anti-inflammatory and anti-infective drugs such as tramadol, metronidazole, and others,”

says a Fact.MR analyst.

animal drug compounding market

Demand for Companion Animal Drugs Surging

Drug compounding products are highly required for companion animals such as dogs, cats, and others. With increase in inclination towards domestication of such animals, suppliers of animal drug compounding products are experiencing surge in demand around the globe.

According to a report titled “U.S. Pet Ownership Statistics”, published by the American Veterinary Medical Association, the percentage of households owning dogs in the United States is 38.4, while 25.4% of U.S. people have cats as their pets. This gives a glimpse of the rising demand for various animal drug compounding products around the globe, such as GI drugs, CNS agents, and others.

Request More Information about Report Methodology
https://www.factmr.com/connectus/sample?flag=RM&rep_id=5796

Competitive Landscape

Key players operating in the animal drug compounding market profiled by Fact.MR includes Wedgewood Pharmacy, Triangle Compounding Pharmacy, Davis Islands Pharmacy, Custom Med Compounding Pharmacy, Central Compounding Center South, Wellness Pharmacy of Cary, Caringbah Compounding Pharmacy, Millers Pharmacy, Smith’s Pharmacy, Specialist Compounding Pharmacy Pvt. Ltd., and Tache Pharmacy. New product launches along with strategic mergers & acquisition remains the core strategy for the market players to thrive in the industry.

For instance, on 14th November 2020, Chewy Pharmacy’s Compounding Ingredients announced the launch of compounding medications for pets.

Also, in October 2020, Wedgewood Pharmacy announced the acquisition of Wildlife Pharmaceuticals Inc. and its subsidiary, ZooPharm, a compounding pharmacy that provides veterinary-anesthesia and pain-management medications to care for non-domestic species, captive exotic breeds and companion animals.

Get More Insights- https://www.biospace.com/article/burgeoning-need-for-cns-agents-and-gi-drugs-will-improve-animal-drug-compounding-demand-fact-mr/

Who is Winning in this Space?

The global animal drug compounding market is highly competitive in nature. In order to sustain its leading positions, key players in this field are bringing in a wider variety of quality products.

For instance,

  • Davis Islands Pharmacy recently launched its new range of products such as GABAPENTIN VET SUSPENSION, FLUOXETINE TRANSDERMAL CREAM, DES CAPSULES, and others.
  • Custom Med Compounding Pharmacy launched its new range of anti-infective therapy solution, transdermal medications, and others, a couple of years back.

Explore Fact.MR’s Coverage on the Healthcare Domain

NGS Data Analysis Market: A new report of Fact.MR envisages the global market for NGS data analysis to record a spectacular growth during the forecast period (2017-2026).

Oncology Small Molecule Drugs Market: Fact.MR’s “Oncology Small Molecule Drugs Market – Global Market Insights 2019-2029,” provides a detailed analysis on the global oncology small molecule drugs market. Size of the oncology small molecule drugs market has been analyzed in a comprehensive way and is presented in terms of value (US$ Mn).

Glaucoma Diagnostics Market: The global Glaucoma Diagnostics market is anticipated to show significant growth as Optical Coherence Tomography (OCT) Imaging Systems, Corneal Pachymeters, Tonometers offers greater advantage over tradition procedures for diagnosis of glaucoma.

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com
Research Insight: https://www.factmr.com/report/animal-drug-compounding-market
Press Release: https://www.factmr.com/media-release/1940/global-animal-drug-compounding-market

Categories
Pharmaceutical

Inclination Towards In-House Sterile API Production to Augment Sales of Non-Aqueous liquid Sterile Active Pharmaceutical Ingredients Says Fact.MR

Global sales of Sterile Active Pharmaceutical Ingredients were valued at US$53 Bn in 2018 and will witness dexterous growth through 2029.

Rising acceptance of biologics and preventive medicines is expected to propel the demand for sterile active pharmaceutical ingredients. Significant accessibility to drugs, growing pharmaceutical spending, and rising demand for targeted therapy drugs are factors boosting sterile active pharmaceutical ingredients market growth. China and India are the prominent suppliers of sterile active pharmaceutical ingredients, globally. Manufacturers are focusing on the expansion of their manufacturing plants in these countries owing to low-cost production and cheap labor.

For detailed insights on enhancing your product footprint, request a sample here- https://www.factmr.com/connectus/sample?flag=S&rep_id=1702

Key Takeaways of Sterile Active Pharmaceutical Ingredients Market Study

  • By product type, monoclonal antibodies accounted for prominent market value share in the sterile active pharmaceutical ingredients market. This is primarily attributed to growing need for biologics and targeted therapies for treatment of chronic disorders such as cancer.
  • South Asia and East Asia collectively hold over 33% of the sterile active pharmaceutical ingredients market share owing to expansion of sterile active pharmaceutical ingredients manufacturing facilities for small API molecules in these regions.
  • Aqueous form is expected to be the dominant segment in the sterile active pharmaceutical ingredients market attributed to the ability to provide great solubility for non-water-soluble drugs.

Need more information about Report Methodology? Click here-
 https://www.factmr.com/connectus/sample?flag=RM&rep_id=1702

 “Increasing investments for sterile fill-finish capabilities expansion and inclination towards in-house sterile API production as a cost reduction strategy by pharmaceutical manufacturers are anticipated to favor the global sterile active pharmaceutical ingredients market growth.” says the Fact.MR Analyst.

Key Segments of the Sterile Active Pharmaceutical Ingredients Market

Fact.MR’s study on the sterile active pharmaceutical ingredients market offers information divided into four important segments-product type, form and region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.

Product Type

  • Monoclonal Antibodies
  • Immunoglobulin
  • Cytokines
  • Insulin
  • Peptide Hormones
  • Blood Factors
  • Peptide Antibiotics
  • Vaccines
  • Small Molecule Antibiotics
  • Highly Potent Active Pharmaceutical Ingredients (HPAPI)
  • Others

Form

  • Aqueous
  • Non-Aqueous Liquid
  • Dry Powder

Region

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa

Full Access of this Exclusive Report is Available at-
https://www.factmr.com/checkout/1702

Emphasis on Manufacturing Capability, Key Strategy Followed by Market Players

Sterile active pharmaceutical ingredients manufacturers are focusing on the expansion of manufacturing facilities and adopting advanced aseptic processing techniques. For instance, in October 2017, Corden Pharma GmbH announced a strategic investment of US$ 4 million in small molecule API development capacity in its Corden Pharma Switzerland facility. With growing investments for infrastructural and technological advancements, manufacturers are also focusing on the opening up of new production plants for sterile active pharmaceutical ingredients in emerging countries. For instance, in October 2018, Sun Pharmaceutical Industries Ltd. opened a new cGMP production line in Guwahati, India to enhance the manufacturing capacity of sterile products.

Looking for more information?

The research study on the sterile active pharmaceutical ingredients market by Fact.MR incorporates an unbiased assessment of key demand-driving factors and trends, which have shaped the landscape of the sterile active pharmaceutical ingredients market over 2014 – 2018 and includes a detailed assessment of key parameters that are anticipated to exert influence during 2019 – 2029. Market statistics have been presented on the basis of product type (monoclonal antibodies, immunoglobulin, cytokines, insulin, peptide hormones, blood factors, peptide antibiotics, vaccines, small molecule antibiotics, highly potent active pharmaceutical ingredients (HPAPI), and others), and form (aqueous, non-aqueous liquid and dry powder) across seven major regions.

For More Insights
https://www.biospace.com/article/as-governments-continue-to-spend-for-healthcare-infra-development-automated-dialysis-concentrated-production-systems-market-to-witness-promising-growth-notes-fact-mr/

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in the US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have in our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
E: sales@factmr.com
Website: https://www.factmr.com
Content Source: https://www.factmr.com/media-release/1292/global-sterile-active-pharmaceutical-ingredient-market

Categories
Pharmaceutical

Smart Pulse Oximeters Market: Awareness Drives for Treatment of COPD and Asthma Remains USP

Continuous technological advancements and introduction of efficient pulse oximeters are the key driving factors for pulse oximeters market growth. The global sales of pulse oximeters were estimated at US$ 1.2 Bn in 2019, and projected to witness moderate growth during the forecast period (2019 – 2029).

“Technological advancements leading to the introduction of new and advanced products and emergence of number of players in the market have intensified pulse oximeter sales,” says a Fact.MR analyst.    

In January 2017, Masimo launched two patient monitoring products in India namely, Rad-97 Pulse-CO Oximeter and SedLine Brain Function Monitoring. These products are expected to improve the patient monitoring capabilities of clinicians. Moreover, government-driven price management and reimbursement controls, particularly in China and Japan, are offering significant opportunities for manufacturers to invest in these regions. Increasing government initiatives to spread awareness related to various respiratory diseases are boosting the sales of pulse oximeter devices.

For detailed insights on enhancing your product footprint, request a sample here-
https://www.factmr.com/connectus/sample?flag=S&rep_id=4449

Key Takeaways of Pulse Oximeter Market Study

  • A large number of companies manufacturing handheld pulse oximeters significantly contributed to the market share in terms of revenue in the pulse oximeters market.
  • North America and Europe collectively hold over 60% of the pulse oximeters market share owing to rapid new product launches in these regions.
  • In terms of end user, hospitals are expected to dominate the pulse oximeters market during the forecast period.
  • The pulse oximeter market is highly fragmented. Some of the prominent manufacturers include Masimo Corp, Medtronic plc., Koninklijke Philips NV, GE Healthcare, Rossmax International Ltd. and few others.

Need more information about Report Methodology? Click here- https://www.factmr.com/connectus/sample?flag=RM&rep_id=4449

Key Segments of Pulse oximeters Market

Fact.MR’s study on the pulse oximeters market offers information divided into three important segments – product type, end user and region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.

Product Type
  • Finger Pulse Oximeters
  • Hand Held Pulse Oximeters
  • Table Top Pulse Oximeters
  • Wrist Pulse Oximeters
End User
  • Hospitals
  • Clinics
  • Ambulatory Surgical Centres
  • Homecare Settings
Region
  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa

Full Access of this Exclusive Report is Available at- https://www.factmr.com/checkout/4449

Awareness Drives for Treatment of COPD and Asthma Remains USP

Several awareness programs have been introduced and promoted by various health organizations or healthcare societies such as online education programs for healthcare professionals, medication maintenance programs and environmental programs, across the globe to control respiratory disorders such as asthma, COPD and other respiratory disease. The introduction and promotion of various awareness programs are expected to increase the growth of pulse oximeters market. These government programs encourage people to adopt early medication, which is expected to increase the revenue generation for the global pulse oximeters market in the forecast years.

pulse oximeters market 2

Looking for More Information?

The research study on pulse oximeter market by Fact.MR incorporates an unbiased assessment of key demand-driving factors and trends, which have shaped the landscape of pulse oximeter over 2014 – 2018 and includes a detailed assessment of key parameters that are anticipated to exert influence over 2019 – 2029. Market statistics have been presented on the basis of product type (finger pulse oximeters, hand held pulse oximeters, table top pulse oximeters and wrist pulse oximeter), and end user (hospitals, clinics, ambulatory surgical centers and homecare settings) across seven major regions.

Get More Insights
https://www.biospace.com/article/thermasonic-ultrasound-gel-warmers-demand-propelled-by-expansion-of-3d-and-doppler-ultrasound-says-fact-mr/

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in the US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have in our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
E: sales@factmr.com
Website: https://www.factmr.com

Categories
Pharmaceutical

Increase In R&D Spending In The Pharmaceutical Industry Opens Up The New Avenues for Cytokines Drugs : Report Fact.MR

Self-administered drugs through pre-filled syringes offer opportunities to reduce consumer spending on caregiver fees. Furthermore, manufacturers are gaining sharper profit margins with the introduction of this drug delivery medium in their portfolio. On this backdrop, the global demand for parenteral drugs was estimated at US$ 451 Bn in 2019, is projected to witness moderate growth during the forecast period (2019 – 2029). Parenteral drug manufactures are currently focused on maintaining high quality of their products.

For detailed insights on enhancing your product footprint, request for a sample here- 
https://www.factmr.com/connectus/sample?flag=S&rep_id=3189

Drugs for cancer are always short in supply in countries where the market is monopolistic and access to such medicines is dominated by a single player. Rising prevalence of chronic illnesses such as cancer, cardiovascular diseases, and diabetes, across the globe has been the prime revenue driver for parenteral drugs and this trend is not likely to abate any time in the foreseeable future.

Key Takeaways of Parenteral Drugs Market Study

  • By product type, monoclonal antibodies segment accounts for maximum market share in terms of revenue in the parenteral drugs market. This is primarily attributed to the rising adoption of biologics and subsequent rise in the number of biologics approved for marketing.
  • North America and Europe collectively hold over 60% of the parenteral drugs market share owing to the rise in new product launches in the regions.
  • Hospital pharmacies segment is expected to be the dominant distribution channel in the parenteral drugs market.
  • The parenteral drugs market is highly fragmented. Some of the prominent parenteral drug manufacturers include, Merck & Co. Inc., Teva Pharmaceutical Industries Ltd., Sanofi S.A., Novartis AG, and Pfizer Inc., among many others.

Need more information about Report Methodology? Click here- https://www.factmr.com/connectus/sample?flag=RM&rep_id=3189

“Patent expiration of branded products and fewer new product launches have resulted in the rise of generic versions of drugs, and in the emergence of a number of players in the market – this factor has intensified total parenteral drugs sales,” says a Fact.MR analyst.

parenteral drugs market 03

Key Segments of Parenteral Drugs Market

Fact.MR’s study on the parenteral drugs market offers information divided into six important segments— product type, application, molecule type, route of administration, distribution channel, and region.

This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.

Product Type
  • Monoclonal Antibodies
  • Immunoglobulin
  • Cytokines
  • Insulin
  • Peptide Hormones
  • Blood Factors
  • Peptide Antibiotics
  • Vaccines
  • Small Molecule Antibiotics
  • Chemotherapy Agents
  • Others
Application
  • Oncology
  • Infectious Diseases
  • Diabetes
  • Blood disorders
  • Hormonal Disorders
  • Musculoskeletal Disorders
  • CNS Diseases
  • Pain Management
  • Cardiovascular Diseases
Molecule Type
  • Small Molecules
  • Large Molecules
Route of Administration
  • Intravenous (IV)
  • Intramuscular (IM)
  • Subcutaneous (SC)
Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Drug Stores
  • Online Pharmacies
Region
  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa

Full Access of this Exclusive Report is Available at-
https://www.factmr.com/checkout/3189

Increased Research Funding to Drive Parenteral Drugs Market Growth

Research funding has surged significantly in recent years, which has resulted in an increase in the number of projects undertaken as well as newly employed personnel for the same. The funding for research comes from governments, private players, and other commercial entities. For instance,

  • In 2017, the National Cancer Institute (NCI) received over US$ 5.6 billion for research initiatives, which reflects a 7% increase as compared to 2016.
  • Similarly, in 2018, in the U.S., the Omnibus Appropriations bill that provided additional funding of US$ 3 billion for the NIH (National Institutes of Health) was passed, which is the highest increase in NIH funding in the past 15 years. This boost in funding, which brings the total NIH investment to US$ 37.1 billion for FY 2018, is expected to speed up cancer research in the coming years.
  • The expected trend indicates a significant rise in NIH funding in the fiscal year 2017 – 2018. In the future, investments in R&D are likely to increase in all countries across the world, especially in countries such as China and Brazil.

For More Insights
https://www.biospace.com/article/canine-influenza-treatment-demand-driven-by-high-unmet-requirement-for-treatment-of-canine-flu-says-fact-mr

Looking for More Information?

The research study on parenteral drugs market by Fact.MR incorporates an unbiased assessment of key demand-driving factors and trends, which have shaped the landscape of parenteral drugs over 2014 – 2018 and includes a detailed assessment of key parameters that are anticipated to exert influence over 2019 – 2029. Market statistics have been presented on the basis of product type (monoclonal antibodies, immunoglobulin, cytokines, indulin, peptide harmones, blood factors, peptide antibiotics, vaccines, small molecule antibiotics, chemotherapy agents, and others), application (oncology, infectious diseases, diabetes, hormonal disorders, musculoskeletal disorders, CNS diseases, pain management and cardiovascular diseases), route of administration (intravenous, intramuscular and subcutaneous), and distribution channel (hospital pharmacies, retail pharmacies, drug stores and online pharmacies) across seven major regions.

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in the US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have in our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
E: sales@factmr.com
Website: https://www.factmr.com

Categories
Pharmaceutical

Sales of Alprazolam Medicine Is Expected to Record a CAGR of Around 2.7% Over the Forcast Period

The demand for benzodiazepine drugs is expected to record a pedestrian CAGR of around 2.7% during the forecast period (2020-2026). The U.S. is expected to account for around one-third of the total share in the global benzodiazepine drugs market by 2026. Growing prevalence of anxiety in parallel with rising awareness regarding benzodiazepine drugs is reflecting on increasing opportunities for players in the U.S. market. As per a report by the Anxiety and Depression Association of America (ADAA), each year, over 40 Mn adults in the U.S. suffer from anxiety disorders.

A comprehensive study by Fact.MR opines that demand for benzodiazepine drugs would remain high-albeit generic ones-which would drive voluminous sales, though contribute moderately to market value.

For detailed insights on enhancing your product footprint, request for a sample here- 

https://www.factmr.com/connectus/sample?flag=S&rep_id=4432

Presence of a large number of hospital and retail pharmacies further makes it easy for individuals to purchase benzodiazepine drugs. A significant influence of high concentration of leading players is also auguring well for the U.S. benzodiazepine drugs market, which has been discussed in detail, in a recent Fact.MR study.

A subject matter expert at Fact.MR opines, “Regulations regarding development of benzodiazepine drugs are relatively stringent in developed regions such as North America and Europe, which opens ground for branded as well as generic drugs in developing regions. As a result, entry barriers in developed regions would be high, while those in developing regions would be moderate.”

analysis of benzodiazepine drugs market by application

Key Highlights of Benzodiazepine Drugs Market Study

  • Easy accessibility is a key feature driving substantial sales of benzodiazepine drugs through retail pharmacies. By 2026, these pharmacies are projected to record value tantamount to US$ 1.4 Bn. Additionally, sales prospects for benzodiazepine drugs are likely to grow during the forecast period, as consumers are evincing high interest in online pharmacies.
  • Popularity of short-acting benzodiazepine drugs is expected to increase during the forecast period, as these induce less hangover effect and take relatively short time of action. On the back of this, around 77% of the total share would be attributable to the sales of short-acting benzodiazepine drugs.
  • Being a highly prevalent disorder among individuals leading a demanding lifestyle, anxiety is projected to account for a sizeable share tantamount to around 53% in the benzodiazepine drugs market during the forecast period.
  • Reduction in the number of prescriptions for benzodiazepine drugs, especially in countries such as the U.S., the U.K., and Canada, would impede market growth during the forecast period.

Need more information about Report Methodology? Click here- https://www.factmr.com/connectus/sample?flag=RM&rep_id=4432

Benzodiazepine Drugs Market – Assessment of Key Segments

Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Others
Time of Action
  • Ultra-short Acting
  • Short Acting
  • Long Acting
Application
  • Anxiety
  • Seizures
  • Insomnia
  • Alcohol Withdrawal
  • Others
Product
  • Alprazolam
  • Clonazepam
  • Diazepam
  • Lorazepam
  • Others
Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Full Access of this Exclusive Report is Available at- https://www.factmr.com/checkout/4432

High Popularity of Generic Drugs Puts Pressure on Branded Products of Leading Players

The benzodiazepine drugs market features fragmentation, as leading players operate under the constant pressure of patent expiration of branded products. High investments made towards the development of innovative and new products by leading players intensifies pressure to achieve the desired RoI. For instance, in 2017, F.Hoffmann-La Roche AG invested around one-fifth of the total revenue to strengthen the pipeline of innovative products. Stringent regulations on innovative drugs further make it difficult for leading players to gain desired marketability.

On the other side, the focus of prominent and leading players is on achieving better penetration into the benzodiazepine drugs market through the development of generic drugs. Growing sales of generic benzodiazepine drugs are putting pressure on leading players to squeeze their profit margins and adopt a cost-competitive strategy to have better sales prospects.

Find More Valuable Insights on Benzodiazepine Drugs Market

Fact.MR, in its new offering, brings to the fore an unbiased analysis of the global benzodiazepine drugs market, presenting historical demand data (2016-2019), and forecast statistics for the period of 2020-2026. The study divulges compelling insights on the benzodiazepine drugs market on the basis of distribution channel (hospital pharmacies, retail pharmacies, and others), time of action (ultra-short acting, short acting, and long acting), application (anxiety, seizures, insomnia, alcohol withdrawal, and others), and product (alprazolam, clonazepam, diazepam, lorazepam, and others), across five major regions.

For More Insights
https://www.biospace.com/article/with-growing-number-of-pet-parents-and-care-awareness-heartworm-treatment-market-is-witnessing-promising-growth/

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in the US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have in our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
E: sales@factmr.com
Website: https://www.factmr.com
Content Source: https://www.factmr.com/media-release/1212/benzodiazepine-drugs-demand